AKT1 and cancer: The enrichment analysis revealed that these “dark genes” and their DEG counterparts were evidently enriched in key signaling pathways, such as JAK–STAT signaling, the PI3K–Akt signaling pathway, the cell cycle, and pathways in cancer, along with other cancer-related pathways (Fig 4B and 4C).